Literature DB >> 16463678

Total arterial revascularization with internal mammary artery or radial artery pi graft configuration.

Yongzhi Deng1, Zongquan Sun, Hugh S Paterson.   

Abstract

To investigate the clinical use of pi graft in total arterial revascularization and its outcomes, a retrospective analysis of 23 patients out of 1000 patients undergoing total arterial coronary bypass surgery with a pi graft between September 1994 and December 2004 was performed. In the selected patients for the management of triple vessel disease with middle diagonal/intermediate ramus disease such that a skip with the left internal mammary artery (LIMA) or radial artery (RA), the main stem of pi graft, to the left anterior descending coronary artery (LAD) will not work and the right internal mammary artery (RIMA) or right gastroepiploic artery (RGEA) cannot pick up the diagonal/intermediate ramus, hence the LAD and diagonal/intermediate ramus were grafted with a mini Y graft using the distal segment of LIMA, RIMA, RA or RGEA, together with the bilateral internal mammary artery (BIMA) or LIMA-RA T graft to compose pi graft. Twenty-three patients (18 males, 5 females) underwent the pi graft procedure. There were no deaths or episodes of myocardial infarction, stroke, and deep sternal wound infection. One patient required reopening for controlling bleeding. Until the end of 2004, during a mean follow-up of 81.0 +/- 28.4 months, no angina needing re-intervention or operative therapy or coronary related death occurred. In conclusion, in patients with specific coronary artery anatomy/stenosis, the BIMA (sometimes LIMA with RA or RGEA) pi graft can be successfully performed for total arterial revascularization with good midterm outcomes.

Entities:  

Mesh:

Year:  2005        PMID: 16463678     DOI: 10.1007/BF02896021

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

1.  Early mortality and morbidity of bilateral versus single internal thoracic artery revascularization: propensity and risk modeling.

Authors:  J P Ioannidis; O Galanos; D Katritsis; C P Connery; G E Drossos; D G Swistel; C E Anagnostopoulos
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

2.  Two internal thoracic artery grafts are better than one.

Authors:  B W Lytle; E H Blackstone; F D Loop; P L Houghtaling; J H Arnold; R Akhrass; P M McCarthy; D M Cosgrove
Journal:  J Thorac Cardiovasc Surg       Date:  1999-05       Impact factor: 5.209

3.  Maximal utilization of the left internal mammary artery for coronary bypass grafting.

Authors:  L I Bonchek; M W Burlingame; B E Vazales; E F Lundy
Journal:  Ann Thorac Surg       Date:  1996-06       Impact factor: 4.330

4.  Retrosternal fat pad for prevention of suppurative sternitis.

Authors:  N K Kejriwal; H S Paterson
Journal:  Ann Thorac Surg       Date:  1997-05       Impact factor: 4.330

5.  The left internal mammary artery as a sequential graft to the left anterior descending system.

Authors:  L R McBride; H B Barner
Journal:  J Thorac Cardiovasc Surg       Date:  1983-11       Impact factor: 5.209

6.  Myocardial revascularization with the left internal thoracic artery Y graft configuration.

Authors:  M K Odayan; H S Paterson
Journal:  Ann Thorac Surg       Date:  1999-05       Impact factor: 4.330

7.  Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries.

Authors:  D P Taggart; R D'Amico; D G Altman
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

8.  The role of the sequential internal mammary artery graft in coronary surgery.

Authors:  A J Tector; T M Schmahl; V R Canino; J R Kallies; D Sanfilippo
Journal:  Circulation       Date:  1984-09       Impact factor: 29.690

9.  Semi-skeletonized internal mammary artery grafts and sternal wound complications.

Authors:  Yongzhi Deng; Karen Byth; Hugh S Paterson
Journal:  Asian Cardiovasc Thorac Ann       Date:  2004-09

10.  Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery. Risk-adjusted survival.

Authors:  B F Buxton; M Komeda; J A Fuller; I Gordon
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.